^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JNJ-6358

    i
    Other names: JNJ-6358, JNJ 78306358, JNJ-78306358
    Associations
    News
    Trials
    Company:
    J&J, Zymeworks
    Drug class:
    CD3 agonist, HLA G inhibitor
    Related drugs:
    Associations
    News
    Trials